Coverage
-
May 29, 2012
Watson Pharmaceuticals Inc. and Endo Pharmaceuticals Inc. have settled all of their outstanding patent litigation related to Watson's generic version of the brand-name lidocaine patch Lidoderm, the drugmakers said Tuesday.
1 other articles on this case.
View all »